Search
Choose your country
Your country:
United Kingdom
Argentina
Australia
Austria
Brazil
Canada
Germany
Ireland
Italy
Malaysia
Mexico
New Zealand
Poland
South Africa
Ukraine
Categories
Top Stories
Business
Health
Tech
Entertainment
Sport
Hot topics
close
Home
Parkinson's disease
Parkinson's disease
Phase 3 clinical trial of ambroxol for Parkinson's confirmed
75
Share on Facebook
Share
Share on Twitter
Tweet
Phase 3 clinical trial of ambroxol for Parkinson's confirmed
UCL launches clinical trial to test if cough medicine ambroxol can slow down Parkinson's disease
Cough Drug Ambroxol Tested as Parkinson's Treatment in Trial
Ambroxol and Parkinson's
Engineered Neurons Could Help Treat Parkinson's
The Precise Neurons That Die In Parkinson's Disease Have Finally Been Identified
A new clue in the search for Parkinson's disease treatments
Brain cells that are linked to Parkinson's disease finally identified
Symptoms of Parkinson's disease 'reversed by brain implant', trial suggests
Parkinson’s patients to be given ‘smart watches’ to monitor their movements
Parkinson's patients to be given 'smart watches' to monitor their movements
Degenerative Disease: Parkinson's Disease (A Case Study)
Signs and symptoms to watch out for Parkinson's disease in the youth
Parkinson's disease symptoms as study identifies two early signs of condition
Early warning signs of Parkinson's disease you should look for
Parkinson's disease: Polyphenol diet 'associated with lower PD risk' – what to eat
New early warning signs of Parkinson's disease are discovered
Hearing loss early sign of Parkinson's
Meet the woman who can smell diseases like cancer and Parkinson's
Cannabis could hold key to preventing neurodegenerative diseases like Parkinson's